Anthony Sinskey, CBI MIT |
Jackie Wolfrum, CBI MIT |
Bruce Levine,
University of Pennsylvania |
David Williams,
Loughborough University |
Knut Niss, Biogen |
(l-r) Dan Gold, BioMarin and
Annie Wang, Northeastern University |
(l-r) Mark Moody, Immunova and
Karen Yuan Mei, MIT |
Brian Teague, MIT |
Chris Ballas, WuXi AppTec |
Michael Washabaugh, MedImmune |
Martha Rook, EMD Millipore |
Brian Hawkins, BioLife Solutions |
Gary C. du Moulin, Massachusetts College of Pharmacy and Health Sciences University |
Denise Gavin, US Food and Drug Administration |
John Duguid, Vericel Corporation |
Alison Wilson, CellData Services |
Bill Lundberg, CRISPR Therapeutics |
Panel Discussion (l-r) Gary C. du Moulin, Anne Plant, and Michael Paglia |
Panel Moderator:
Jackie Wolfrum, CBI MIT |
(l-r) Stacy Springs, CBI MIT,
Bill Hancock, Northeastern University and TIM the Beaver, MIT |